Vitamin C inhibits platelet expression of CD40 ligand

Free Radical Biology and Medicine

Volumn 38, Issue 12, 2005, Pages 1662-1666

  Pignatelli, Pasquale ^a   Sanguigni, Valerio ^b   Paola, Sciacca Giordano ^a   Lo Coco, Emanuela ^a   Lenti, Luisa ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Free radicals free radical scavengers; Platelets; Reactive oxygen species; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CD40 LIGAND; COLLAGEN; PLACEBO; SCAVENGER; SUPEROXIDE;

AGONIST; ANTIGEN EXPRESSION; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG INFUSION; HUMAN; IN VIVO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS; VITAMIN BLOOD LEVEL;

ADULT; ANTIOXIDANTS; ARACHIDONIC ACIDS; ASCORBIC ACID; BLOOD PLATELETS; CD40 LIGAND; COLLAGEN; FEMALE; GENE EXPRESSION; HUMANS; INDOLES; MALE; PHOSPHOLIPASES A; PROTEIN KINASE C; SUPEROXIDES; THROMBIN;

LETHRINIDAE;

EID: 19444374789     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.02.032     Document Type: Article

References (11)

1. U. Schoenbeck, and P. Libby The CD40/CD154 receptor/ligand dyad Cell. Mol. Life Sci. 58 2001 4 43
2. P. André, L. Nannizzi-Alaimo, S.K. Prasad, and D.R. Phillips Platelet-derived CD40L: the switch-hitting player of cardiovascular disease Circulation 106 2002 896 899
3. P. Pignatelli, L. Lenti, V. Sanguigni, G. Frati, I. Simeoni, P.P. Gazzaniga, F.M. Pulcinelli, and F. Violi Carnitine inhibits arachidonic acid accumulation into platelet phospholipids. Effects on platelet function and oxidative stress Am. J. Physiol. Heart Circ. Physiol. 284 1 2003 H41 H48
4. P. Pignatelli, V. Sanguigni, L. Lenti, D. Ferro, A. Finocchi, A. Rossi, and F. Violi gp91phox-dependent expression of platelet CD40 ligand Circulation 110 2004 1326 1329
5. A.C. Carr, B.Z. Zhu, and B. Frei Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E) Circ. Res. 87 2000 349 354
6. F. Mach, U. Schonbeck, and G.K. Sukhova Reduction of atherosclerosis in mice by inhibition of CD40 signalling Nature 394 1998 200 203
7. U. Schonbeck, N. Gerdes, N. Varo, R.S. Reynolds, D.B. Horton, U. Bavendiek, L. Robbie, P. Ganz, S. Kinlay, and P. Libby Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells Circulation 106 2002 2888 2893
8. P. Aukrust, F. Muller, T. Ueland, T. Berget, E. Aaser, A. Brunsvig, N.O. Solum, K. Forfang, S.S. Froland, and L. Gullestad Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes Circulation 100 1999 614 620
9. N. Varo, J.A. de Lemos, P. Libby, D.A. Morrow, S.A. Murphy, R. Nuzzo, C.M. Gibson, C.P. Cannon, E. Braunwald, and U. Schonbeck Soluble CD40L: risk prediction after acute coronary syndromes Circulation 108 2003 1049 1052
10. C. Heeschen, S. Dimmeler, C.W. Hamm, M.J. van den Brand, E. Boersma, A.M. Zeiher, and M.L. Simoons CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes N. Engl. J. Med. 348 2003 1163 1165
11. C. Weber, W. Erl, K. Weber, and P.C. Weber Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers Circulation 93 1996 1488 1492